Solventum Corp SEC filings SOLV
Solventum Corp has 261 filings in SEC EDGAR's recent list, going back to Feb 14, 2023. Its latest annual report, Form 10-K, was filed on Feb 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 20, 2026 | Jul 16, 2026 |
| 8-K |
Current report
Other events
|
Jun 5, 2026 | Jun 2, 2026 |
| SD | Specialized disclosure (conflict minerals) | May 29, 2026 | — |
| 8-K |
Current report
Officer or director change
|
May 27, 2026 | May 21, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 20, 2026 | May 15, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| DEFA14A | Additional proxy material | Mar 27, 2026 | — |
| DEF 14A | Proxy statement | Mar 27, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 24, 2026 | Mar 20, 2026 |
| 10-K | Annual report | Feb 27, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 16, 2025 | Dec 16, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 21, 2025 | Oct 17, 2025 |
| 8-K |
Current report
Other events
|
Sep 8, 2025 | Sep 8, 2025 |
| 8-K |
Current report
Acquisition or sale of assets, Regulation FD disclosure
|
Sep 2, 2025 | Sep 1, 2025 |
| 8-K |
Current report
Other events
|
Aug 22, 2025 | Aug 22, 2025 |
| 8-K |
Current report
Other events
|
Aug 15, 2025 | Aug 13, 2025 |
| 424B7 | Filing | Aug 14, 2025 | — |
| 424B7 | Filing | Aug 14, 2025 | — |
| FWP | Free writing prospectus | Aug 13, 2025 | — |
| S-3ASR | Automatic shelf registration | Aug 13, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 13, 2025 | Aug 13, 2025 |
| 10-Q | Quarterly report | Aug 8, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Material agreement
|
Jun 25, 2025 | Jun 25, 2025 |
| SD | Specialized disclosure (conflict minerals) | May 30, 2025 | — |
| 10-Q | Quarterly report | May 9, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 2, 2025 | Apr 30, 2025 |
| ARS | Annual report to shareholders | Mar 21, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Mar 21, 2025 | — |
| DEF 14A | Proxy statement | Mar 21, 2025 | Dec 31, 2024 |
| IRANNOTICE | Filing | Feb 28, 2025 | — |
| 10-K | Annual report | Feb 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement
|
Feb 27, 2025 | Feb 25, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2025 | Feb 27, 2025 |
| EFFECT | Filing | Dec 17, 2024 | — |
| POS AM | Filing | Dec 11, 2024 | — |
| EFFECT | Filing | Dec 2, 2024 | — |
| 424B3 | Prospectus | Dec 2, 2024 | — |
| CORRESP | Letter to the SEC | Nov 26, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 20, 2024 | — |
| CORRESP | Letter to the SEC | Nov 19, 2024 | — |
| S-4 | Registration for a merger or exchange | Nov 15, 2024 | — |
| IRANNOTICE | Filing | Nov 8, 2024 | — |
| 10-Q | Quarterly report | Nov 8, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 5, 2024 | Oct 30, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 26, 2024 | Sep 20, 2024 |
| IRANNOTICE | Filing | Aug 9, 2024 | — |
| 10-Q | Quarterly report | Aug 9, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Officer or director change
|
May 17, 2024 | May 13, 2024 |
| 10-Q | Quarterly report | May 10, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 16, 2024 | Apr 12, 2024 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Other events
|
Apr 4, 2024 | Mar 31, 2024 |
| S-8 | Employee stock plan registration | Apr 1, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2024 | Mar 13, 2024 |
| SEC STAFF ACTION | Filing | Mar 13, 2024 | — |
| SEC STAFF LETTER | Filing | Mar 13, 2024 | — |
| CORRESP | Letter to the SEC | Mar 12, 2024 | — |
| CERT | Nyse certification | Mar 12, 2024 | — |
| 10-12B/A | Filing | Mar 11, 2024 | — |
| 10-12B/A | Filing | Mar 6, 2024 | — |
| CORRESP | Letter to the SEC | Mar 5, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 1, 2024 | — |
| SEC STAFF LETTER | Filing | Feb 27, 2024 | — |
| CORRESP | Letter to the SEC | Feb 20, 2024 | — |
| 10-12B | Filing | Feb 20, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 15, 2024 | — |
| DRSLTR | Filing | Feb 9, 2024 | — |
| DRS/A | Filing | Feb 9, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 5, 2024 | — |
| DRSLTR | Filing | Jan 26, 2024 | — |
| DRS/A | Filing | Jan 26, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 5, 2024 | — |
| DRS/A | Filing | Dec 18, 2023 | — |
| DRSLTR | Filing | Sep 13, 2023 | — |
| DRS/A | Filing | Sep 13, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 11, 2023 | — |
| DRSLTR | Filing | Jul 28, 2023 | — |
| DRS/A | Filing | Jul 28, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 10, 2023 | — |
| DRSLTR | Filing | Jun 23, 2023 | — |
| DRS/A | Filing | Jun 23, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 6, 2023 | — |
| DRS/A | Filing | May 16, 2023 | — |
| DRSLTR | Filing | May 15, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 15, 2023 | — |
| DRS | Filing | Feb 14, 2023 | — |
Showing 97 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- SOLV (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Eagan, MN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1964738
- Former names
- 3M Health Care Co (until Feb 9, 2024)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.